Among the mesenchymal type of cancers such as rhabdomyosarcoma and osteosarcoma cells, it has been suggested that the IL4R pathway might be a therapeutic target of these types of cancers [16, 17]. This evidence concerns the gene IL4R and rhabdomyosarcoma.